Cell Therapy Development and Manufacturing is based on state-of-the-art technology and requires specific, hard-to-find expertise.

While it’s necessary to mitigate long-term risk, you also want to ensure a rapid path to market and sufficient flexibility if your plans change. That’s where we can help. If you need to produce a Cell Therapy, Necstgen offers a wide range of services and expert professionals. 

How we accelerate your path to market?

By delivering a complete solution from start to end and providing unmatched access to scientific expertise, we can enable your success.

Development

• Translational activities to create GMP compliant manufacturing
• Process design and optimisation
• Scale-up to clinically relevant volumes
• Automation and closed processes

 

Manufacturing

• Pre-clinical or toxicology study material
• Phase I to Phase III clinical trial material

 

Cell Therapies

Talk to NecstGen today about your needs for:

• Induced Pluripotent Stem Cells (iPSC)
• Chimeric Antigen Receptor T-Cells (CAR-T), Tumor Infiltrating Lymphocytes (TIL), and T-Cell Receptor Modified T-Cells (TCR-T)
• Natural Killer (NK) Cells/CAR-NK Cells
• Dendritic Cells (DC)
• Mesenchymal Stromal Cells (MSC)